Intratumoral HER2 IHC heterogeneity (i.e., uneven distribution of HER2 expression or different intensities of HER2 staining in tumor cells) is more frequent in HER2-low (2 + or 1 + IHC score) samples [30]. Here, ERBB2 is linked to neoplasm.